Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship of Pulmonary Artery to Aorta Ratio With Pulmonary Vascular Resistance, Compliance, and Outcomes in COPD and Interstitial Lung Disease in PVDOMICS.

Pulmonary circulation·2026
Same author

Spatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.

European journal of radiology·2025
Same author

Editorial for "Left Ventricular Hemodynamic Forces Changes in Fabry Disease: A Cardiac Magnetic Resonance Study".

Journal of magnetic resonance imaging : JMRI·2025
Same author

Pulmonary hypertension across the spectrum of left heart and lung disease.

European journal of heart failure·2024
Same author

Arrhythmogenic Left Ventricular Mass as the Initial Presentation of Cardiac Sarcoidosis.

JACC. Case reports·2024
Same author

Novel contouring method for optimizing MRI flow quantification in patients with aortic valve disease.

The international journal of cardiovascular imaging·2024
Same journal

Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care.

Heart failure clinics·2026
Same journal

Long-term Complications of Pulmonary Embolism: Which Is the Optimal Follow-Up?

Heart failure clinics·2026
Same journal

Recent Advances in Pulmonary Hypertension Management.

Heart failure clinics·2026
Same journal

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension.

Heart failure clinics·2026
Same journal

Portopulmonary Hypertension: Current Perspectives.

Heart failure clinics·2026
Same journal

Exercise Training and Cardiac Rehabilitation in Chronic Thromboembolic Pulmonary Hypertension.

Heart failure clinics·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Myocardial viability and revascularization.

Anne S Kanderian1, Rahul Renapurkar, Scott D Flamm

  • 1Cleveland Clinic, Cleveland, OH 44195, USA.

Heart Failure Clinics
|July 1, 2009
PubMed
Summary
This summary is machine-generated.

Cardiovascular MRI, particularly delayed-enhancement MRI (DE-MRI), accurately assesses myocardial viability. This advanced imaging technique is becoming a new gold standard for evaluating heart muscle damage.

More Related Videos

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Related Experiment Videos

Last Updated: Jun 22, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Area of Science:

  • Cardiovascular Imaging
  • Medical Diagnostics

Background:

  • Assessing myocardial viability is crucial for diagnosing and managing heart conditions.
  • Current noninvasive imaging techniques have limitations in accuracy and scope.

Purpose of the Study:

  • To evaluate the accuracy and utility of cardiovascular MRI, specifically delayed-enhancement MRI (DE-MRI), for assessing myocardial viability.
  • To establish DE-MRI as a new gold standard in myocardial viability assessment.

Main Methods:

  • Cardiovascular MRI was used to assess multiple markers of myocardial viability.
  • The delayed-enhancement MRI (DE-MRI) technique was employed, leveraging its high spatial resolution.
  • Correlative pathologic data were utilized to validate imaging findings.

Main Results:

  • Cardiovascular MRI demonstrated accuracy at least equivalent, if not superior, to other noninvasive techniques like positron emission tomography.
  • DE-MRI's high spatial resolution and correlation with pathologic data make it powerful for detecting viable and damaged myocardium.
  • Clinical data support DE-MRI as a new gold standard for myocardial viability assessment.

Conclusions:

  • DE-MRI is a highly accurate and comprehensive tool for myocardial viability assessment.
  • The technique is poised for wider clinical adoption in analyzing dysfunctional myocardium.
  • DE-MRI will be integrated into diagnostic and therapeutic algorithms for cardiovascular disease.